Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and inter...
XTNT: Expanded sales force and new product launches drive growth and profitability in regenerative biologics
Xtant Medical Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its fY26 sales guidance.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Xtant Med | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 23.03 M
Xtant Medical hosted annual shareholder meeting, quorum met 74.47% of shares
Xtant Medical schedules Q2 results conference call